Local view for "http://purl.org/linkedpolitics/eu/plenary/2007-07-09-Speech-1-101"
Predicate | Value (sorted: default) |
---|---|
rdf:type | |
dcterms:Date | |
dcterms:Is Part Of | |
dcterms:Language | |
lpv:document identification number |
"en.20070709.16.1-101"2
|
lpv:hasSubsequent | |
lpv:speaker | |
lpv:spokenAs | |
lpv:translated text |
"With regard to this report, I subscribe to all of the observations made by the rapporteur.
Out of an original budget of EUR 969 million, the Commission has cut healthcare allocations to EUR 365 million. It did so despite the fact that Parliament had not regarded EUR 969 million as sufficient and had topped it up to EUR 1.5 billion. I view this cut of nearly 60% as highly irresponsible. It is all the more shocking in the current climate, with healthcare systems across Eastern Europe weakened by the exodus of large numbers of physicians and nurses, who are leaving to seek work in the EU-15. In a situation where other programmes have been cut to the tune of a mere 2 to 5% and when every third citizen in Europe develops cancer, I believe that in assuming this stance the Commission is ridiculing and disparaging the patients and citizens of the European Union. It is therefore necessary to support the rapporteur in his efforts to have this small budget increased by at least 10%, that is, to EUR 402 million, while keeping the variation ceiling at no more than 5%.
At the same time, the programme should explicitly stipulate that structural funds, as you mentioned, Commissioner, can be used to finance healthcare projects, provided that Member States designate health care as a priority in their national programmes. Until now, these funds have been primarily used to finance environmental projects or build up infrastructure, and only a few citizens know that the funds could also be employed to finance the modernisation of hospitals, purchase equipment and train healthcare professionals.
I very much welcome the establishment of European-wide registries for major diseases, notably cancer, which will be instrumental in collecting data and highlighting even more the fact that there are discrepancies of up to 30% between Member States in the survival rates of patients suffering from certain types of cancer. On the basis of statistics such as these, I believe that the Commission will review its healthcare priorities and endorse the appropriate allocations."@en1
|
Named graphs describing this resource:
The resource appears as object in 2 triples